Development of CYP8B1-specific inhibitors for metabolic diseases.
- DOI
- 10.64898/2026.10.20.760253
- Published
- 2026 Oct 21
- Container
- bioRxiv : the preprint server for biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.10.20.760253,
title = {Development of CYP8B1-specific inhibitors for metabolic diseases.},
author = {Fang Z and Agua ARL and Jossart J and Sharma N and Lyu X and Wang Z and Zhang S and Sun J and Shi L and Ayard J and Chang M and Liu J and Kou K and Shively J and Garcia-Ocana A and Horne D and Yin H and Jin L and Perry JJP and Huang W},
year = {2026},
journal = {bioRxiv : the preprint server for biology},
doi = {10.64898/2026.10.20.760253},
url = {https://doi.org/10.64898/2026.10.20.760253}
}RIS
TY - JOUR TI - Development of CYP8B1-specific inhibitors for metabolic diseases. AU - Fang Z AU - Agua ARL AU - Jossart J AU - Sharma N AU - Lyu X AU - Wang Z AU - Zhang S AU - Sun J AU - Shi L AU - Ayard J AU - Chang M AU - Liu J AU - Kou K AU - Shively J AU - Garcia-Ocana A AU - Horne D AU - Yin H AU - Jin L AU - Perry JJP AU - Huang W PY - 2026 JO - bioRxiv : the preprint server for biology DO - 10.64898/2026.10.20.760253 UR - https://doi.org/10.64898/2026.10.20.760253 ER -
APA
Z, F., ARL, A., J, J., N, S., X, L., Z, W., S, Z., J, S., L, S., J, A., M, C., J, L., K, K., J, S., A, G., D, H., H, Y., L, J., JJP, P., & W, H. (2026). Development of CYP8B1-specific inhibitors for metabolic diseases.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.20.760253
Source records
- pubmed · retrieved 2026-11-10T10:55:07.071Z